IceCure Medical
ICCM
7 hedge funds and large institutions have $3.34M invested in IceCure Medical in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.04% more ownership
Funds ownership: 0% → 0.04% (+0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.09M |
| 2 |
Jane Street
New York
|
+$393K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$223K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$32K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$27K |
Top Sellers
ICCM Hedge Fund Activity: Q3 2021 in Review
7 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q3 2021, worth a combined $3.34M.
Buyers outnumbered sellers: 7 funds opened new ICCM positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was ARK Investment Management, opening a new position worth an estimated $3.09M.
- 7 institutional investors held IceCure Medical (ICCM) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $3.34M of IceCure Medical stock for Q3 2021.
- 7 funds opened new IceCure Medical positions in Q3 2021 and 0 closed out, a net change of +7 holders.
- The largest IceCure Medical buyer in Q3 2021 was ARK Investment Management, an estimated $3.09M added.
Based on aggregated 13F filings for Q3 2021.